XML 25 R9.htm IDEA: XBRL DOCUMENT
v3.10.0.1

EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY: | 3 Months Ended
--- | ---
Jun. 30, 2018
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY: |
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY: | PER SHARE AND STOCKHOLDERS’ EQUITY: Loss Per Share A reconciliation of the numerator and denominator of basic and diluted loss per share is shown below (in thousands, except per share amounts):
|  | For the three months ended
|  | June 30,
|  | 2018 |  | 2017
Basic loss per share: |  |  |  |  |
Net loss |  | $ | (3,015 | ) |  | $ | (1,300 | )
Basic weighted-average shares outstanding |  | 76,935 |  |  | 78,672 |
Basic loss per share |  | $ | (0.04 | ) |  | $ | (0.02 | )
Diluted loss per share: |  |  |  |  |  |
Basic weighted-average shares outstanding |  | 76,935 |  |  | 78,672 |
Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method |  | — |  |  | — |
Diluted weighted-average shares outstanding |  | 76,935 |  |  | 78,672 |
Diluted loss per share |  | $ | (0.04 | ) |  | $ | (0.02 | )
Due to the net loss incurred by the Company during the quarters ended June 30, 2018 and 2017, the dilutive effect of options, warrants and restricted stock units covering 2.4 million and 2.8 million shares of common stock, respectively, was excluded from the diluted loss per share calculation since the impact on the calculation was anti-dilutive. Additional options and warrants to purchase shares of common stock and restricted stock units that were outstanding during the periods presented but were not included in the computation of diluted loss per share because the effect was anti-dilutive are shown below (shares in thousands):
|  | For the three months ended
|  | June 30,
|  | 2018 |  | 2017
Number of shares outstanding under options, warrants and restricted stock units |  | 119 |  |  | 20 |
Range of exercise prices for options |  | $32.85 |  |  | $32.85 |
Stockholders’ Equity On August 29, 2011, the board of directors adopted a common stock repurchase program. That program was subsequently modified and expanded, most recently on March 30, 2018. Under the modified common stock repurchase program, the Company may purchase up to $500.0 million of its common stock through the period ending December 31, 2019. During the three months ended June 30, 2018, the Company repurchased 1.9 million shares of its common stock for $45.8 million. Through June 30, 2018, the Company had repurchased a total of 22.0 million shares of its stock for $420.4 million, leaving remaining capacity of $79.6 million under the stock repurchase program. Accumulated Other Comprehensive Income Accumulated other comprehensive income accumulated balances of $8.9 million and $10.8 million at June 30, 2018 and March 31, 2018, respectively, reflect accumulated foreign currency translation adjustments.

X
- References No definition available. + Details
Name: | acxm_EarningsPerShareAndStockholdersEquityDisclosureAbstract
Namespace Prefix: | acxm_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosures related to accounts comprising shareholders' equity, including other comprehensive income and used to capture the complete disclosure pertaining to an entity's earnings per share. + References No definition available. + Details
Name: | acxm_EarningsPerShareAndStockholdersEquityDisclosureTextBlock
Namespace Prefix: | acxm_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration